Blood Transfusion Diagnostics Market Size & Share, by Product Type (Instruments, Reagents & Kits); Application (Blood Group Typing, Blood Screening); End-user (Hospital Based Laboratories, Blood Banks) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2033

  • Report ID: 4481
  • Published Date: Feb 23, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2033

Blood Transfusion Diagnostics Market size is anticipated to reach USD 9 billion by the end of 2033, growing at a CAGR of 4% during the forecast period, i.e., 2023-2033. In the year 2022, the industry size of blood transfusion diagnostics was over USD 4 billion. The market growth is primarily driven by a growing number of people with kidney malfunction. Kidney failure, commonly known as chronic kidney disease (CKD), is a disorder in which the kidneys are unable to adequately eliminate waste and excess fluids from the blood. This can result in a variety of problems, including anemia, which is frequent in CKD patients. Regular blood transfusions are frequently required for CKD patients to manage anemia, as well as other problems like hemorrhage, coagulation, and infection. Around 850 million people are suffering from some kind of kidney problem. Additionally, around 121,000 people in the United States need kidney transplantation.

Higher instances of injury and deaths caused by road accidents are to propel the growth of the global blood transfusion market. Road traffic accidents are a serious public health issue and a leading source of fatalities and injuries worldwide. These incidents frequently lead to serious injuries that need urgent medical attention and blood transfusions. The rising frequency of traffic accidents and related injuries is expected to boost the demand for blood. Approximately, 3,700 people die globally every day in vehicle crashes or being hit by a vehicle. Furthermore, the increased pressure of chronic disease in the world and the urgent requirement for blood donation due to the shortage of blood donations during the pandemic are the few factors expected to propel the market growth.


Blood Transfusion Diagnostics Market
Get more information on this report: Request Free Sample PDF

Blood Transfusion Diagnostics Sector: Growth Drivers and Challenges

Growth Drivers

  • Higher Number of People in Need of Dialysis- Dialysis is a kidney failure treatment that filters the blood to remove unwanted toxins, waste products, and excess fluids. When the kidneys fail, the body may struggle to clean the blood and keep the system chemically balanced. This is estimated to boost the blood transfusion diagnostics market during the forecast period. Globally, approximately 5-10 million people need dialysis or transplantation. Moreover, the prevalence of chronic kidney disorder is nearly 10% in men and around 11% in women.
  • Growing Prevalence of Chronic Disease – Chronic diseases such as cancer, cardiovascular diseases, leukemia, and other autoimmune diseases may require a blood transfusion. According to the World Health Organization, chronic cardiovascular disease is the leading cause of death in the world. additionally, around 18 million people died of cardiovascular disease.
  • Need to Fill the Blood Shortage Caused During Pandemic - Blood shortages have been caused by COVID-19's impact on supply chains and blood donation networks. This is especially concerning during emergencies since operations and emergency medical treatment frequently require blood. The market for blood transfusion diagnostics may expand as a result of the growing need for diagnostic tools and tests to check for these diseases. During COVID-19, the activity of blood donation decreased by around 40% to 67%, which caused a huge shortage of blood in the entire world and the number of blood donors in various countries decreased by about 20-30%.
  • Increased Cases of Road Accidents – Road accidents often lead to urgent emergency room (ER) visits, which may require blood for transfusion immediately. By the report of the World Health Organization, around 1.3 million people, every day dies in road accidents.

 Challenges

  • Shortage of Technologists to Perform Automated Autotransfusion - Advanced systems such as nucleic acid amplification test, and centrifugal machines used to separate blood cells requires skilled professionals, therefore, the lack of expert professionals is hampering the market growth.
  • Lack of appropriate Infrastructure
  • High Cost of Instruments, Tests & Treatment Required for Blood Transfusions

Blood Transfusion Diagnostics Market: Key Insights

Base Year

2022

Forecast Year

2023-2033

CAGR

~4%

Base Year Market Size (2022)

~USD 4 Billion

Forecast Year Market Size (2033)

~USD 9 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Blood Transfusion Diagnostics Segmentation

Application (Blood Group Typing, Blood Screening)

The blood transfusion diagnostics market is segmented and analyzed for demand and supply by application into blood group typing and blood screening. Out of the two, the blood screening segment is anticipated to hold the largest market size by the end of 2033. Rising blood donations and transfusions are likely to boost the growth of the segment. By the statistics of the WHO, about 119 million of blood is donated every year all around the world. In addition, the growing penetration of sexually transmitted diseases, hepatitis B, and HIV are driving the segment’s growth. According to the Centers for Disease Control and Prevention, around 296 million people are living with hepatitis B worldwide. Moreover, as per the World Health Organization, the prevalence of STDs has impacted more than 1 million people all over the world.

End-user (Hospital Based Laboratories, Blood Banks)

The global blood transfusion diagnostics market is also segmented and analyzed for demand and supply by end-user in hospital-based laboratories and blood banks. Out of these segments, hospital-based laboratories are projected to secure a higher market share by 2033. This can be owed to the fact that hospital-based laboratories are better equipped to conduct the complicated and crucial screening procedures necessary for blood transfusions since they are furnished with cutting-edge machinery and technology and operated by qualified personnel. Additionally, these labs are in a good position to provide patients with a variety of diagnostic services such as blood typing. Also, hospitals are expanding their diagnostic capabilities to satisfy the rising need for blood products as the demand for blood transfusions rises. For instance, it was found that there were about 6100 hospitals in the U.S. in 2022.

Our in-depth analysis of the global market includes the following segments:

      By Product Type

  • Instruments
  • Reagents & Kits

       By Application

  • Blood Group Typing
  • Blood Screening

        By End-User

  • Hospital Based Laboratories
  • Blood Banks

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Blood Transfusion Diagnostics Industry - Regional Synopsis

APAC Market Statistics

The Asia Pacific blood transfusion diagnostics market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033. It is driven by aspects such as the rising need for blood transfusions, the developing healthcare infrastructure in the area, and the rising public awareness of the value of blood donation and testing. A considerable portion of the Asia Pacific blood transfusion diagnostics market is anticipated to increase in countries like China and India owing to their big populations and quickly growing healthcare infrastructure. Other countries in the area are also anticipated to develop as well due to factors such as the rise in hospital-based diagnostic labs and the desire for quick and precise blood tests.

North American Market Forecast

The North American blood transfusion diagnostics market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033. A higher number of road accidents taking place in the region is driving the market growth in North America. As of 2022, more than 6 million vehicle crashes took place in the United States. The growth is also attributed to the lack of blood during COVID-19, which in turn is propelling the requirement for blood donation. Since March 2020, the rate of blood donation dropped by about 10% and there has been about a 62% decrease in blood drives across colleges and schools.

Research Nester
Blood Transfusion Diagnostics Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Blood Transfusion Diagnostics Landscape

top-features-companies
    • Immucor, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Bio-Rad Laboratories, Inc.
    • Danaher Corporation
    • Quotient Limited
    • Beckman Coulter, Inc.
    • DiaSorin S.p.A.
    • BD (Becton, Dickinson, and Company)
    • Ortho Clinical Diagnostics
    • Grifols, S.A.
    • Thermo Fisher Scientific Inc.

In-the-news

In The News

  • Danaher Corporation announced the acquisition of Aldervon. Aldervon was the only operating company within Danaher’s Life Sciences segment.

  • Grifols S.A. announced the acquisition of Biotest to boost the development and innovation of its product portfolio, increasing the availability of plasma therapy for patients.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4481
  • Published Date: Feb 23, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing cases of COVID-19, rising road accidents, a dearth of blood donations, and a higher number suffering from kidney issues and chronic disease are the few factors likely to propel the market growth.

The market is anticipated to attain a CAGR of 4% over the forecast period, i.e., 2023-2033.

The dearth of skilled technicians, exorbitant prices of tests and instruments, and shortage of infrastructure are the few factors that are likely to hamper the market growth.

The market in the North American region is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.

The major players in the market are Immucor, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Quotient Limited, Beckman Coulter, Inc., DiaSorin S.p.A., BD (Becton, Dickinson, and Company), Ortho Clinical Diagnostics, Grifols, S.A., Thermo Fisher Scientific Inc., and so on…

The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by product type, application, end-user, and by region.

Blood screening is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Blood Transfusion Diagnostics Market Report Scope
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying